Page last updated: 2024-09-05

1,3-dipropylxanthine and denbufylline

1,3-dipropylxanthine has been researched along with denbufylline in 1 studies

Compound Research Comparison

Studies
(1,3-dipropylxanthine)
Trials
(1,3-dipropylxanthine)
Recent Studies (post-2010)
(1,3-dipropylxanthine)
Studies
(denbufylline)
Trials
(denbufylline)
Recent Studies (post-2010) (denbufylline)
26003921

Protein Interaction Comparison

ProteinTaxonomy1,3-dipropylxanthine (IC50)denbufylline (IC50)
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.0851
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.0851
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.0851
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.0851

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hasegawa, T; Iwasaki, N; Konno, K; Kurita, M; Miyamoto, K; Ohshima, T; Sakai, R; Sanae, F; Takagi, K; Yamamoto, Y1

Other Studies

1 other study(ies) available for 1,3-dipropylxanthine and denbufylline

ArticleYear
Bronchodilator activity of xanthine derivatives substituted with functional groups at the 1- or 7-position.
    Journal of medicinal chemistry, 1993, May-14, Volume: 36, Issue:10

    Topics: Administration, Oral; Animals; Bronchial Spasm; Bronchodilator Agents; Guinea Pigs; Heart Rate; Male; Mice; Muscle Relaxation; Structure-Activity Relationship; Trachea; Xanthines

1993